Valneva Se ADR (VALN)

$5.50 -0.10 (-1.74%)
Market Cap 476.53M
Revenue (ttm) 183.50M
Net Income (ttm) -13.25M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -7.22%
Debt to Equity Ratio 1.03
Volume 1,600
Avg Vol 40,896
Day's Range N/A - N/A
Shares Out 85.09M
Stochastic %K 8%
Beta 1.81
Analysts Strong Sell
Price Target $13.85

Company Profile

Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera or heat-labile toxin producing enterotoxigenic Escherichia coli bacterium; and IXCHIQ/ VLA1553, a single-dose, live-a...

Industry: Biotechnology
Sector: Healthcare
Phone: 33 2 28 07 37 10
Fax: 33 2 28 07 37 11
Website: valneva.com
Address:
6 rue Alain Bombard, Saint-Herblain, France
Siuolman58
Siuolman58 Jun. 17 at 7:48 PM
$VALN Just waiting for the Lyme Vaccine!!! Big Winner!
0 · Reply
stocksmanagement
stocksmanagement Jun. 5 at 9:38 PM
$VALN Check out this article from TipRanks | Valneva Announces Positive Phase 2 Results for Chikungunya Vaccine in Children | https://tipranks.onelink.me/WJho/bbal0dvw
0 · Reply
stocksmanagement
stocksmanagement Jun. 5 at 9:37 PM
$VALN good news
0 · Reply
TedBaker08
TedBaker08 Jun. 5 at 5:42 PM
$VALN good news keep coming
0 · Reply
Dackel1909
Dackel1909 May. 20 at 8:23 PM
$VALN 🤩
0 · Reply
Tjcmd
Tjcmd May. 17 at 6:21 PM
$VALN ho hum
0 · Reply
Skywulf
Skywulf May. 12 at 7:59 AM
$VALN sadly we will see all pharma go down hard this week ☠️
0 · Reply
TheCheeseWrangler
TheCheeseWrangler May. 7 at 3:54 PM
$VALN https://valneva.com/press-release/valneva-provides-update-following-european-medicines-agency-announcement-on-use-of-ixchiqin-elderly/
0 · Reply
Boonkers
Boonkers May. 7 at 5:16 AM
$VALN https://valneva.com/press-release/valneva-reports-first-quarter-2025-financial-results-and-provides-corporate-updates/
0 · Reply
TheCheeseWrangler
TheCheeseWrangler May. 7 at 5:01 AM
$VALN https://valneva.com/press-release/valneva-reports-first-quarter-2025-financial-results-and-provides-corporate-updates/
0 · Reply
Latest News on VALN
Valneva Announces Successful Outcome of its Annual General Meeting, Confirms FY 2025 guidance

Jun 25, 2025, 11:45 AM EDT - 13 hours ago

Valneva Announces Successful Outcome of its Annual General Meeting, Confirms FY 2025 guidance

UK's MHRA suspends Valneva's chikungunya vaccine for elderly

Jun 9, 2025, 10:29 AM EDT - 16 days ago

UK's MHRA suspends Valneva's chikungunya vaccine for elderly

Valneva Reports Positive Six-Month Antibody Persistence and Safety Phase 2 Results in Children for its Single-Shot Chikungunya Vaccine IXCHIQ®

Jun 5, 2025, 11:45 AM EDT - 20 days ago

Valneva Reports Positive Six-Month Antibody Persistence and Safety Phase 2 Results in Children for its Single-Shot Chikungunya Vaccine IXCHIQ®

Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update

Jun 4, 2025, 1:00 AM EDT - 21 days ago

Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update

Valneva to Participate at U.S. and European Investor Conferences in June

May 26, 2025, 11:30 AM EDT - 4 weeks ago

Valneva to Participate at U.S. and European Investor Conferences in June

Valneva Provides Update on Recommended Use of IXCHIQ® by Elderly Individuals in the United States

May 12, 2025, 1:00 AM EDT - 6 weeks ago

Valneva Provides Update on Recommended Use of IXCHIQ® by Elderly Individuals in the United States

Valneva SE (VALN) Q1 2025 Earnings Call Transcript

May 9, 2025, 9:47 AM EDT - 6 weeks ago

Valneva SE (VALN) Q1 2025 Earnings Call Transcript

Valneva SE: Still Undervalued Travel Vaccine Bet With Robust 2025 Guidance

May 8, 2025, 12:30 AM EDT - 7 weeks ago

Valneva SE: Still Undervalued Travel Vaccine Bet With Robust 2025 Guidance

Valneva Provides Update Following European Medicines Agency Announcement on Use of IXCHIQ® in Elderly

May 7, 2025, 11:45 AM EDT - 7 weeks ago

Valneva Provides Update Following European Medicines Agency Announcement on Use of IXCHIQ® in Elderly

Europe reviews Valneva's chikungunya vaccine after reports of serious side-effects in older people

May 7, 2025, 8:40 AM EDT - 7 weeks ago

Europe reviews Valneva's chikungunya vaccine after reports of serious side-effects in older people

Valneva Reports First Quarter 2025 Financial Results and Provides Corporate Updates

May 7, 2025, 1:00 AM EDT - 7 weeks ago

Valneva Reports First Quarter 2025 Financial Results and Provides Corporate Updates

Valneva Provides Update on Recommendation for Use of Its Chikungunya Vaccine by French Authorities

Apr 26, 2025, 1:10 PM EDT - 2 months ago

Valneva Provides Update on Recommendation for Use of Its Chikungunya Vaccine by French Authorities

Valneva Provides Update on ACIP Recommendation for its Chikungunya Vaccine IXCHIQ® Among U.S. Travelers

Apr 18, 2025, 4:00 AM EDT - 2 months ago

Valneva Provides Update on ACIP Recommendation for its Chikungunya Vaccine IXCHIQ® Among U.S. Travelers

Valneva to Participate in Multiple Events at the 25th World Vaccine Congress, including a Presentation on its Chikungunya Vaccine IXCHIQ®

Apr 16, 2025, 11:45 AM EDT - 2 months ago

Valneva to Participate in Multiple Events at the 25th World Vaccine Congress, including a Presentation on its Chikungunya Vaccine IXCHIQ®

Brazil Approves Valneva's Mosquito-Borne Chikungunya Vaccine

Apr 14, 2025, 2:28 PM EDT - 2 months ago

Brazil Approves Valneva's Mosquito-Borne Chikungunya Vaccine

Valneva Receives First Marketing Authorization for IXCHIQ® in a Chikungunya Endemic Country

Apr 14, 2025, 11:45 AM EDT - 2 months ago

Valneva Receives First Marketing Authorization for IXCHIQ® in a Chikungunya Endemic Country

Valneva and LimmaTech Announce First Vaccination in Phase 2 Infant Study of Tetravalent Shigella Vaccine Candidate S4V2

Apr 9, 2025, 1:00 AM EDT - 2 months ago

Valneva and LimmaTech Announce First Vaccination in Phase 2 Infant Study of Tetravalent Shigella Vaccine Candidate S4V2

VALN Investors Have Opportunity to Join Valneva SE Fraud Investigation with the Schall Law Firm

Apr 7, 2025, 9:33 AM EDT - 2 months ago

VALN Investors Have Opportunity to Join Valneva SE Fraud Investigation with the Schall Law Firm

Valneva SE Shareholding Declaration - March 2025

Apr 3, 2025, 11:45 AM EDT - 2 months ago

Valneva SE Shareholding Declaration - March 2025

Valneva's Chikungunya Vaccine IXCHIQ® Now Authorized in EU for Adolescents Aged 12 and Above

Apr 1, 2025, 11:45 AM EDT - 3 months ago

Valneva's Chikungunya Vaccine IXCHIQ® Now Authorized in EU for Adolescents Aged 12 and Above

Valneva Submits Adolescent Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to UK MHRA

Mar 31, 2025, 1:00 AM EDT - 3 months ago

Valneva Submits Adolescent Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to UK MHRA

Valneva Renews its Sales Agreement in connection with its Existing At-the-Market (ATM) Program

Mar 26, 2025, 1:00 PM EDT - 3 months ago

Valneva Renews its Sales Agreement in connection with its Existing At-the-Market (ATM) Program

Valneva Announces Filing of 2024 Universal Registration Document and US Form 20-F

Mar 25, 2025, 2:00 AM EDT - 3 months ago

Valneva Announces Filing of 2024 Universal Registration Document and US Form 20-F

Valneva Responds to French Government's Call for Vaccine Supply of IXCHIQ® against Chikungunya Outbreak in La Réunion

Mar 24, 2025, 2:00 AM EDT - 3 months ago

Valneva Responds to French Government's Call for Vaccine Supply of IXCHIQ® against Chikungunya Outbreak in La Réunion

Valneva SE (VALN) Q4 2024 Earnings Call Transcript

Mar 20, 2025, 8:00 PM EDT - 3 months ago

Valneva SE (VALN) Q4 2024 Earnings Call Transcript

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Valneva SE (VALN) and Encourages Stockholders to Learn More About the Investigation

Mar 20, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Valneva SE (VALN) and Encourages Stockholders to Learn More About the Investigation

Valneva Reports Full Year 2024 Results and Provides Business Updates and Outlook

Mar 20, 2025, 2:00 AM EDT - 3 months ago

Valneva Reports Full Year 2024 Results and Provides Business Updates and Outlook

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Valneva SE (VALN) And Encourages Shareholders to Reach Out

Mar 19, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Valneva SE (VALN) And Encourages Shareholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Valneva SE (VALN) and Encourages Shareholders to Learn More About the Investigation

Mar 18, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Valneva SE (VALN) and Encourages Shareholders to Learn More About the Investigation

Valneva SE (VALN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Mar 17, 2025, 10:00 AM EDT - 3 months ago

Valneva SE (VALN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages Valneva SE (VALN) Shareholders to Inquire about Securities Investigation

Mar 16, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Valneva SE (VALN) Shareholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating Valneva SE (VALN) And Encourages Investors to Connect

Mar 14, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Valneva SE (VALN) And Encourages Investors to Connect

Bronstein, Gewirtz & Grossman, LLC Encourages Valneva SE (VALN) Stockholders to Inquire about Securities Investigation

Mar 13, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Valneva SE (VALN) Stockholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Valneva SE (VALN) and Encourages Investors to Learn More About the Investigation

Mar 12, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Valneva SE (VALN) and Encourages Investors to Learn More About the Investigation

Valneva SE (VALN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Mar 11, 2025, 10:00 AM EDT - 3 months ago

Valneva SE (VALN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating Valneva SE (VALN) And Encourages Stockholders to Connect

Mar 9, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Valneva SE (VALN) And Encourages Stockholders to Connect

Valneva SE (VALN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Mar 7, 2025, 10:00 AM EST - 3 months ago

Valneva SE (VALN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Valneva SE (VALN) and Encourages Stockholders to Learn More About the Investigation.

Mar 6, 2025, 10:00 AM EST - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Valneva SE (VALN) and Encourages Stockholders to Learn More About the Investigation.

Bronstein, Gewirtz & Grossman, LLC Encourages Valneva SE (VALN) Investors to Inquire about Securities Investigation

Mar 5, 2025, 10:00 AM EST - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Valneva SE (VALN) Investors to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Valneva SE (VALN) And Encourages Investors to Reach Out

Mar 4, 2025, 1:45 PM EST - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Valneva SE (VALN) And Encourages Investors to Reach Out

Valneva to Present at Upcoming TD Cowen and Van Lanschot Kempen Healthcare Investor Conferences

Mar 3, 2025, 1:00 AM EST - 4 months ago

Valneva to Present at Upcoming TD Cowen and Van Lanschot Kempen Healthcare Investor Conferences

Valneva Receives EMA's Positive CHMP Opinion for Adolescent Label Extension for Chikungunya Vaccine IXCHIQ®

Feb 28, 2025, 11:45 AM EST - 4 months ago

Valneva Receives EMA's Positive CHMP Opinion for Adolescent Label Extension for Chikungunya Vaccine IXCHIQ®

Valneva Reports Preliminary Unaudited 2024 Revenue and Cash and Provides 2025 Outlook

Feb 18, 2025, 1:00 AM EST - 4 months ago

Valneva Reports Preliminary Unaudited 2024 Revenue and Cash and Provides 2025 Outlook

Valneva Receives Marketing Authorization in the UK for the World's First Chikungunya Vaccine, IXCHIQ®

Feb 5, 2025, 1:00 AM EST - 5 months ago

Valneva Receives Marketing Authorization in the UK for the World's First Chikungunya Vaccine, IXCHIQ®

Valneva Announces New IXIARO® Supply Contract with the U.S. Government Worth a Minimum of $32.8 Million

Jan 30, 2025, 11:45 AM EST - 5 months ago

Valneva Announces New IXIARO® Supply Contract with the U.S. Government Worth a Minimum of $32.8 Million

Siuolman58
Siuolman58 Jun. 17 at 7:48 PM
$VALN Just waiting for the Lyme Vaccine!!! Big Winner!
0 · Reply
stocksmanagement
stocksmanagement Jun. 5 at 9:38 PM
$VALN Check out this article from TipRanks | Valneva Announces Positive Phase 2 Results for Chikungunya Vaccine in Children | https://tipranks.onelink.me/WJho/bbal0dvw
0 · Reply
stocksmanagement
stocksmanagement Jun. 5 at 9:37 PM
$VALN good news
0 · Reply
TedBaker08
TedBaker08 Jun. 5 at 5:42 PM
$VALN good news keep coming
0 · Reply
Dackel1909
Dackel1909 May. 20 at 8:23 PM
$VALN 🤩
0 · Reply
Tjcmd
Tjcmd May. 17 at 6:21 PM
$VALN ho hum
0 · Reply
Skywulf
Skywulf May. 12 at 7:59 AM
$VALN sadly we will see all pharma go down hard this week ☠️
0 · Reply
TheCheeseWrangler
TheCheeseWrangler May. 7 at 3:54 PM
$VALN https://valneva.com/press-release/valneva-provides-update-following-european-medicines-agency-announcement-on-use-of-ixchiqin-elderly/
0 · Reply
Boonkers
Boonkers May. 7 at 5:16 AM
$VALN https://valneva.com/press-release/valneva-reports-first-quarter-2025-financial-results-and-provides-corporate-updates/
0 · Reply
TheCheeseWrangler
TheCheeseWrangler May. 7 at 5:01 AM
$VALN https://valneva.com/press-release/valneva-reports-first-quarter-2025-financial-results-and-provides-corporate-updates/
0 · Reply
Armonica423
Armonica423 May. 7 at 1:59 AM
$VALN CYDY
0 · Reply
Chalutz
Chalutz May. 7 at 12:02 AM
$DVAX I also have a position in $VALN with its Lyme Disease vaccine. So glad to know DVAX mgmt is on the job flipping their shares, doing nothing in Europe and RIDICULOUSLY behind Pfizer and Valneva’s Lyme disease vaccine. Tute investors have to side with us and get rid of these crooks.
0 · Reply
ajmore
ajmore May. 2 at 6:19 AM
$VALN RFK Jr. US to invest 500 mln in "new" Covid vaccine with whole virus inactivated! Are they going to buy the Valneva vaccine!
0 · Reply
TedBaker08
TedBaker08 Apr. 29 at 11:56 AM
$VALN
0 · Reply
MoneyAndAdderall
MoneyAndAdderall Apr. 28 at 1:47 PM
$VALN CDC states that at least four of these five individuals had also received other vaccines, and most of them had significant underlying medical conditions.
0 · Reply
MoneyAndAdderall
MoneyAndAdderall Apr. 28 at 1:45 PM
$VALN buy the dip, the CDC that at least four of these five individuals over 65 with adversed effects from chikungunya vaccine had also received other vaccines, and most of them had significant underlying medical conditions
0 · Reply
Skywulf
Skywulf Apr. 28 at 1:42 PM
$VALN ouch the hospitalizations and freeze on being allowed to use the vaccine are going to hurt on this
0 · Reply
dangerm0815
dangerm0815 Apr. 28 at 11:30 AM
$VALN https://endpts.com/france-stops-valnevas-chikungunya-vaccine-rollout-in-over-65s-after-safety-issue/?u=1ed685a1-977f-4d12-a0a9-cdbf0a6c0aa5&s=email&c=ead60ced-92750c9c-06b1291d&utm_medium=email&utm_campaign=899%20-%20Valnevas%20vaccine%20safety%20setback%20Plus%20news%20from%20AACR%20Basic&utm_content=899%20-%20Valnevas%20vaccine%20safety%20setback%20Plus%20news%20from%20AACR%20Basic+CID_a71fafc90f086d49520535642db31f51&utm_source=ENDPOINTS%20emails&utm_term=France%20stops%20Valnevas%20chikungunya%20vaccine%20rollout%20in%20over%2065s%20after%20safety%20issue
1 · Reply
ajmore
ajmore Apr. 28 at 6:32 AM
$VALN Buy the dip! this is the norm in any drug or vaccine deployment. Statement emphasises on vaccination campaign 14-65 still on! Expect resuming with age 65+ too very soon once clear, usually 5-10 days. Buy the dip!
1 · Reply
TedBaker08
TedBaker08 Apr. 23 at 10:22 AM
$VALN
0 · Reply
Boonkers
Boonkers Apr. 16 at 3:57 PM
$VALN https://valneva.com/press-release/valneva-to-participate-in-multiple-events-at-the-25th-world-vaccine-congress-including-a-presentation-on-its-chikungunya-vaccine-ixchiq/
0 · Reply
JarvisFlow
JarvisFlow Apr. 15 at 11:30 AM
HC Wainwright & Co. updates rating for Valneva ( $VALN ) to Buy, target set at 17.
0 · Reply